The last Corp deck on their site dates back to Nov '22. It...

The last Corp deck on their site dates back to Nov '22. It states there are readouts for 4/5 trials in 1H '23, 3 for pax and 1 for evt. it is way beyond time that they informed us as to what the status is on these. They need to either run a townhall or get the PI's out talking about the data. They are out of $ again shortly, none of us deserve another huge dilution.

There are 3 paths for pax to an NDA, a combination of dipg accelerated with a PRV while starting a pivotal for brain mets would be transformative, hopefully triggers a buyout from Merck or Pfizer!

Kazia are at Bio Boston this week, let's hope they are courting some suitors with bags of Covid cash.